Magali Reyes

Statistics

Publications

Citations

278

H-Index

Active since

1995

Affiliations

Johnson & Johnson (United States)(Current)

Magali Reyes is an author at Johnson & Johnson (United States) specializing in disruptive behavior disorder treatment, psychopharmacology, and behavioral disorders in childhood.

Publications per year

1995–2006

Publications

A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders

Magali Reyes, Jan K. Buitelaar, Paz Toren et al. · American Journal of Psychiatry · 2006 · 156 citations

Medicine, Pharmacotherapy, Psychiatry +17

Long-Term Use of Risperidone in Children with Disruptive Behavior Disorders and Subaverage Intelligence: Efficacy, Safety, and Tolerability

Magali Reyes, Jan Croonenberghs, Ilse Augustyns et al. · Journal of Child and Adolescent Psychopharmacology · 2006 · 69 citations

Medicine, Pharmacotherapy, Psychiatry +17

Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders

Magali Reyes, Róza Oláh, Krisztina Csaba et al. · European Child & Adolescent Psychiatry · 2006 · 41 citations

Medicine, Pediatrics, Pharmacotherapy +14

Functional properties of regenerated optic axons terminating in the primary olfactory cortex

Frank Scalia, Arthur C. Grant, Magali Reyes et al. · Brain Research · 1995 · 12 citations

Life Sciences, Neurobiology, Neuroscience +16

1–4 of 4